Immune therapy shows early promise for advanced leukemia
(HealthDay)—An experimental therapy that targets the immune system might offer a new way to treat an often deadly form of adult leukemia, a preliminary study suggests.
Cancer
Mar 20, 2013 |
5 / 5 (3) |
0
|
Study casts light on deadly immune response
(Medical Xpress)—Examining a case study of near-death experiences for six healthy men who volunteered to test an experimental drug in London has yielded important insights into potentially deadly over-reactions ...
Immunology
Mar 19, 2013 |
3 / 5 (2) |
1
|
Novel anti-clotting drug more effective than Plavix in coronary procedures, study says
(Medical Xpress)—An experimental drug has been shown to be significantly more effective at preventing blood clots during coronary stenting procedures compared to the anti-clotting agent now typically used, according to ...
Cardiology
Mar 11, 2013 |
not rated yet |
0
|
Exercise can slow onset of Alzheimer's memory loss, study reports
(Medical Xpress)—Keeping active can slow down the progression of memory loss in people with Alzheimer's disease, a study has shown. A team of researchers from The University of Nottingham has identified ...
Alzheimer's disease & dementia
Jan 24, 2013 |
5 / 5 (2) |
0
|
Lilly drug chosen for Alzheimer's prevention study (Update)
Researchers have chosen an experimental drug by Eli Lilly & Co. for a large federally funded study testing whether it's possible to prevent Alzheimer's disease in older people at high risk of developing it.
Alzheimer's disease & dementia
Jan 18, 2013 |
not rated yet |
0
Treatment for cocaine addiction targets relapse
(Medical Xpress)—What is the best intervention window for someone struggling with cocaine addiction? When he or she is in the middle of a drug binge, or after a period of abstinence when there is temptation ...
Psychology & Psychiatry
Jan 15, 2013 |
not rated yet |
0
|
Drug companies forge partnerships with top schools
(AP)—Pharmaceutical companies that can no longer rely on lucrative patents to drive profits are increasingly teaming up with academia in search of the next big drug discovery.
Medications
Jan 10, 2013 |
3 / 5 (1) |
0
New drug for bipolar disorder may offer fewer side effects
(Medical Xpress)—A drug for bipolar disorder that works like lithium, the most common and effective treatment for the condition, but without lithium's toxicity and problem side-effects has been identified ...
Psychology & Psychiatry
Jan 09, 2013 |
4.8 / 5 (5) |
0
|
Experimental graft-vs.-host disease treatment equivalent to standard care in Phase 3 trial
An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3 trial at the American Society of ...
Cancer
Dec 10, 2012 |
not rated yet |
0
Research identifies targeted molecular therapy for untreatable NF1 tumors
Researchers conducting a preclinical study in mice successfully used targeted molecular therapy to block mostly untreatable nerve tumors that develop in people with the genetic disorder Neurofibromatosis 1 (NF1).
Cancer
Dec 10, 2012 |
5 / 5 (2) |
0
|
New drug regimens may slow advanced breast cancer
(HealthDay)—An experimental cancer drug may delay the progression of some advanced breast cancers, while a double dose of an existing cancer drug could help women live longer, according to separate studies ...
Cancer
Dec 05, 2012 |
not rated yet |
0
Research shows immune system response is detrimental to novel brain cancer therapy
For the first time, researchers have demonstrated that the response of natural killer (NK) cells is detrimental to glioblastoma virotherapy, a novel way of treating malignant brain cancer by injecting a virus into the tumor. ...
Cancer
Dec 04, 2012 |
not rated yet |
0
Promising drug slows down advance of Parkinson's disease and improves symptoms
Treating Parkinson's disease patients with the experimental drug GM1 ganglioside improved symptoms and slowed their progression during a two and a half-year trial, Thomas Jefferson University researchers report in a new study ...
Parkinson's & Movement disorders
Nov 29, 2012 |
5 / 5 (2) |
0
|
Testing pain killers on humans could save money and speed the arrival of new drugs
Deliberately inflicting carefully controlled painful stimuli on human volunteers and seeing how well specific drugs reduce the feeling of pain can be an effective way of testing new drugs. So conclude two researchers who ...
Medications
Nov 08, 2012 |
5 / 5 (1) |
0
New drug may help those who can't take statins
(HealthDay)—An experimental drug may help patients who can't tolerate statins lower their cholesterol, a new Australian study suggests.
Cardiology
Nov 05, 2012 |
4 / 5 (3) |
0
|
